SCHEMBL20205075

SCHEMBL20205075

CC1C[C@]2(CC[C@@H](N3C(=O)c4ccccc4C3O)CC2)C(=O)N1c1ccc(F)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
CASP6 P55212 1/20 0.37
IDO1 P14902 1/20 0.34
ALDH1A1 P00352 2/20 0.34
RAB9A P51151 2/20 0.34
ATM Q13315 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALOX15 P16050 1/20 0.34
CTSD P07339 1/20 0.33
GRM4 Q14833 1/20 0.33
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
KCNH2 Q12809 1/20 0.32
SCN5A Q14524 1/20 0.32
SCN9A Q15858 1/20 0.32
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18208388 0.85 KMT2A (0.42) P2RX7MEN1KMT2AGAACASP6
SCHEMBL18216046 0.85 KMT2A (0.42) P2RX7MEN1KMT2AGAACASP6
SCHEMBL18208643 0.80 PSEN1 (0.39) P2RX7MEN1KMT2AGAACASP6
SCHEMBL18209064 0.76 PSEN1 (0.39) P2RX7MEN1KMT2AGAACASP6
SCHEMBL18216089 0.76 PSEN1 (0.39) P2RX7MEN1KMT2AGAACASP6
SCHEMBL18208503 0.69 BACE1 (0.32) P2RX7PDK1PDK2PDK3PDK4
SCHEMBL20798796 0.69 MEN1 (0.43) MEN1KMT2AGAAALDH1A1RAB9A
SCHEMBL20118180 0.69 P2RX7 (0.41) P2RX7DRD2DRD4
SCHEMBL19539757 0.68 TSHR (0.52) MEN1KMT2AALDH1A1RAB9AATM
SCHEMBL18208871 0.67 KMT2A (0.44) P2RX7MEN1KMT2AGAACASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES C1R, C9, C1S P2RX7 1358/4885MEN1 56/4885KMT2A 3502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.